In BCa, ATF3 has been found to regulate gelsolin-mediated remodeling of actin cytoskeleton to suppress tumor metastasis [35] amd can be utilized as a potential marker of the response to histone deacetylase inhibitor mediated therapy in bladder cancer [47]. Here, ATF3 is linked to urinary bladder cancer.